Whole Health: A Signature in Exchange for Patients

The fraud case against Whole Health’s physician-owner centered on standing urine-test orders exchanged for a stream of addiction-treatment patients, according to the Justice Department’s criminal case summary. That summary describes allegations that treatment facilities sent specimens to laboratories, then sent patients to Whole Health for more testing and treatment. The signature that authorized one set of bills also brought the clinic its next patients.

Whole Health was a private clinic in Delray Beach, Florida, offering addiction treatment, family care and urgent care. Its owner’s medical-director relationships reached across Palm Beach County. For someone working in a clinic, treatment center or laboratory, the case connects decisions that can sit in different departments: who authorized the test, who delivered the patient, what care occurred and who billed for it.

Standing Test Orders Allegedly Traded for Patients

According to the Justice Department’s summary of the criminal charges, the physician became a facility’s medical director for a nominal fee and signed standing orders authorizing medically unnecessary urine testing. The facilities, in return, had to send their patients to Whole Health and its staff for additional services.

The alleged reach was substantial: more than 50 addiction treatment facilities and over 136 standing orders. A signature could support laboratory claims outside the clinic while bringing patients into the owner’s own billing operation. The medical-director title made the arrangement look clinical. The required patient visits supplied its commercial purpose.

The Justice Department’s account of the court documents describes facilities routinely sending urine specimens to clinical testing laboratories. Those laboratories billed health care benefit programs for unnecessary tests that often cost thousands of dollars apiece. Facilities required patients to visit Whole Health regularly or allowed its staff to come onsite for testing and treatment.

That onsite option matters. The arrangement could generate additional Whole Health services even when the patient stayed at the treatment facility.

How the Patient Flow Supported More Billing

The Justice Department’s summary of the criminal allegations describes laboratories, treatment facilities and the physician benefiting from the same stream of patients. Laboratories could bill for the tests. Facilities and sober homes could also bill for unnecessary testing and sometimes received a laboratory kickback for each specimen. The physician could bill for additional excessive and duplicative services when those patients reached his practice.

Where laboratories paid per specimen, more samples meant more payments to the facility. The physician’s benefit came through the clinic visits his signature secured.

In addiction treatment, the referral itself can carry substantial business work. AAC Holdings’ annual report describing its admissions operation placed benefits verification, insurer communications, screening, facility selection and logistics in a centralized admissions center. Those functions show why a patient referral can connect insurance coverage, placement and billable care before a clinician writes a treatment note.

In the Whole Health charging account, that connection was explicit: patient delivery was a condition of the physician signing the orders. We see the absurdity in calling someone a medical director while making access to patients part of the price of his signature. The patients came seeking addiction care. Their movement through the system became part of the billing arrangement.

Tests Allegedly Left Unused in Treatment

The Justice Department’s summary of the criminal charges says the physician allegedly did not meaningfully review the test results or use them to treat patients. That allegation goes beyond the number of specimens collected. It concerns what happened after the laboratory produced an answer.

The Justice Department’s description says urine and blood tests were authorized and conducted to generate revenue, with results left unused in patient treatment. A clinic employee might see the orders and incoming results. A laboratory worker might see the requisitions and testing volume. Someone handling claims might see repeated charges. Putting those views together exposes the question at the center of the allegation: what did the ordered test contribute to this patient’s care?

For this kind of case, we connect the reason recorded for a test with the order, the result, the clinician’s review and the service billed. A standing authorization is only one part of that account. We look for what the clinician did with the information the test produced.

The same summary describes allegedly excessive and duplicative treatments following tests at both the facilities and Whole Health. Looking at a laboratory requisition alone can miss the additional tests and encounters billed elsewhere for the same person.

Alleged Billing for Therapy That Never Happened

The alleged false billing extended beyond unnecessary tests to services that never occurred. According to the charging documents summarized on the Justice Department’s case page, the physician billed for psychiatric services and therapy sessions that did not happen and that he and his staff were not qualified to conduct.

The same account includes allegedly fraudulent office-visit claims. It describes the physician using nurse practitioners and other medical staff in his practice to bill private insurers fraudulently. It alleges that some patients were billed between $10,000 and $20,000 for a single day’s visit to the physician and Whole Health.

For a person who worked there, the appointment schedule, staff assignments, encounter notes and billed service describe different parts of that day. We examine how those accounts fit together. The person who knows what actually happened during a visit may understand a claim in a way that its billing code alone cannot convey.

Alleged Improper Prescribing

The Justice Department’s criminal case summary also describes allegations of improper prescribing of buprenorphine/Suboxone. It says the physician frequently exceeded the number of patients he was then authorized to treat, provided the drugs to patients who did not need them and ignored evidence of possible diversion.

That adds a different clinical concern to the unused test results. For an employee who saw how prescriptions were approved, the prescribing decisions may be the part of the business they know best.

What Insurers Were Billed and What They Paid

The Justice Department’s charging summary puts the scheme from approximately May 2011 through March 2020. It says private insurers and Medicare were fraudulently billed approximately $746 million for laboratory testing and other services, and paid approximately $127 million.

We trace which business submitted each claim and which payer paid it, connecting the laboratory bills to the additional encounters at the clinic.

The Physician’s Guilty Plea

Whole Health’s physician-owner pleaded guilty on October 4, 2022, to conspiracy to commit health care and wire fraud, according to the Justice Department’s criminal case page.

The FBI Miami Division Palm Beach Resident Agency investigated the case. The Justice Department brought it as part of its Sober Homes Initiative.

Automatic Testing in a Separate Civil Case

The PremierTox and SelfRefind settlement illustrates how a testing arrangement can also become a civil fraud case. The Kentucky laboratory, addiction-treatment business and physician owners agreed to pay $15,750,000 to resolve allegations involving unnecessary testing and billing, in a settlement announced in February 2014.

The government alleged that comprehensive urine testing became automatic after physicians acquired laboratory ownership. The allegations also covered medically unnecessary testing of frozen samples after a delay and claims for more expensive tests than those actually performed.

Both cases connect a business arrangement to the tests ordered for a patient. The alleged incentive at Whole Health was access to patients; in Kentucky, it was laboratory ownership. In each, the clinical reason for the testing was the question.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Saw How the Patients Reached the Clinic

If you saw standing orders traded for patient visits, repeated testing without clinical review or therapy billed without a session, speak to one of our Whistleblower Experts about what happened inside the clinic. We work beside you to build your strongest addiction-treatment whistleblower case around the clinical decisions and money trail, bring in addiction-treatment fraud whistleblower lawyers, and stay with you through the pursuit of a recovery.